PHARMACOLOGICAL STUDIES ON SA446, A NEW ANGIOTENSIN I-CONVERTING ENZYME-INHIBITOR

被引：0
|
作者：
ISO, T [1 ]
YAMAUCHI, H [1 ]
SUDA, H [1 ]
NAKAJIMA, N [1 ]
NISHIMURA, K [1 ]
TAKADA, T [1 ]
HORIUCHI, M [1 ]
NAKATA, K [1 ]
IWAO, J [1 ]
机构：
[1] SANTEN PHARMACEUT CO LTD,RES LAB,HIGASHIYODOGAWA KU,OSAKA 533,JAPAN
来源：
JAPANESE JOURNAL OF PHARMACOLOGY | 1980年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P136 / P136
页数：1
相关论文
共 50 条
  • [1] SPECIES-DIFFERENCE OF SA446, A NOVEL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR
    ISO, T
    YAMAUCHI, H
    IWATANI, T
    KITO, H
    HORIUCHI, M
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (1-2) : 321 - 322
  • [2] RENAL EXCRETION OF AN ANGIOTENSIN-I CONVERTING ENZYME-INHIBITOR (SA-446) IN DOGS
    ABE, Y
    OKAHARA, T
    MIURA, K
    YUKIMURA, T
    TAKADA, T
    IWATANI, T
    ISO, T
    YAMAMOTO, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 325 (04) : 356 - 359
  • [3] PHARMACOLOGICAL STUDY OF ALACEPRIL, AN ANGIOTENSIN I-CONVERTING ENZYME-INHIBITOR, IN HEALTHY-VOLUNTEERS
    OGIHARA, T
    KUMAHARA, Y
    HOSOKI, K
    HAYASHI, K
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 42 (02): : 324 - 334
  • [4] RENAL EXCRETORY MECHANISM OF AN ANGIOTENSIN CONVERTING ENZYME-INHIBITOR (SA-446) IN DOGS
    ABE, Y
    MIURA, K
    YUKIMURA, T
    TAKADA, T
    OKAHARA, T
    YAMAMOTO, K
    FOLIA PHARMACOLOGICA JAPONICA, 1983, 81 (02) : P25 - P25
  • [5] EFFECTS OF AN ANGIOTENSIN-I-CONVERTING ENZYME-INHIBITOR (SA-446) ON RENAL-FUNCTION IN DOGS
    TAKADA, T
    YAMAMOTO, K
    FUJIOKA, S
    TAMAKI, T
    FUKUI, K
    ABE, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1985, 38 (02): : 227 - 230
  • [6] ANGIOTENSIN I-CONVERTING ENZYME-INHIBITOR DERIVED FROM AN ENZYMATIC HYDROLYSATE OF CASEIN .3. EFFECTS OF ZINC ION ON INHIBITION BY ANGIOTENSIN I-CONVERTING ENZYME-INHIBITOR DERIVED FROM CASEIN
    MARUYAMA, S
    SUZUKI, H
    TOMIZUKA, N
    AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1985, 49 (09): : 2809 - 2810
  • [7] SA446, A NEW ORALLY ACTIVE CONVERTING ENZYME-INHIBITOR - ANTIHYPERTENSIVE ACTION AND COMPARISON WITH CAPTOPRIL IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    UNGER, T
    YUKIMURA, T
    MARINGREZ, M
    LANG, RE
    RASCHER, W
    GANTEN, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 78 (04) : 411 - 420
  • [8] PHARMACOLOGICAL PROFILE OF TRANDOLAPRIL, A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    CONEN, H
    BRUNNER, HR
    AMERICAN HEART JOURNAL, 1993, 125 (05) : 1525 - 1531
  • [9] PHARMACOKINETIC PROPERTIES OF A NEW ANGIOTENSIN I-CONVERTING ENZYME-INHIBITOR IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    ONOYAMA, K
    KUMAGAI, H
    INENAGA, T
    NANISHI, F
    OKUDA, S
    OH, Y
    OMAE, T
    HAYASHI, K
    FUJISHIMA, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 39 (05): : 671 - 680
  • [10] EFFECTS OF ANGIOTENSIN I-CONVERTING ENZYME-INHIBITOR, SQ-14225, IN NORMAL MEN
    KONO, T
    IKEDA, F
    OSEKO, F
    IMURA, H
    ENDO, J
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1979, 1 (04) : 542 - 542
12345